US Drug Recall Register
Class III · Low risk Terminated Initiated Apr 5, 2013 (13 years ago)

Glenmark Gabapentin Tablets

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Chemical Contamination: Gabapentin Sodium tablets is recalled due to complaints related to an off - odor described as moldy, musty or fishy in nature.

What was recalled

Glenmark Gabapentin Tablets, a) 600mg, 500- count bottle (NDC 68462-126-05), b) 800 mg, 500- count bottle (NDC 68462-127-05), Rx only, Manufactured by Glenmark Generics Ltd.Colvale- Bardez Ltd 403513, India, Manufactured for : Glenmark Generics USA Mahwah, NJ 07430.

Recalling firm
Glenmark Generics Inc., USA
NDC code
68462-126-05
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-329-2013

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Gabapentin recalls

See all
Class II · Moderate risk Ongoing

Gabapentin Capsules

Reason Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity .

The Harvard Drug Group LLC NDC 0904-6665-61 D-0031-2026
Class II · Moderate risk Ongoing

Gabapentin Capsules

Reason Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity .

The Harvard Drug Group LLC NDC 0904-6665-61 D-0030-2026
Class II · Moderate risk Ongoing

Gabapentin Capsules

Reason Defective container; blister packaging inadequately sealed.

The Harvard Drug Group LLC NDC 55154-3363-0 D-0508-2025
Class II · Moderate risk Ongoing

Gabapentin Capsules

Reason Defective container; blister packaging inadequately sealed.

The Harvard Drug Group LLC NDC 0904-6665-61 D-0507-2025
Class II · Moderate risk Ongoing

Gabapentin Tablets 600mg

Reason CGMP Deviations

Glenmark Pharmaceuticals Inc., USA NDC 68462-126-05 D-0320-2025